Browsing "Faculty of Pharmacy" by Subject
Showing results 1 to 20 of 54
next >
- acute pancreatitis, biochemistry, markers 1
- Allelic variants; Drug metabolizing enzymes; Drug target; 1
- Alprazolam, low-content active pharmaceutical ingredient, API, quantification, partial least squares, PLS, Raman spectroscopy, mid-infrared, near-infrared 1
- Amlodipine, Atorvastatin, Sustainable method, HPLC, Whiteness assessment, Greenness evaluation 1
- Anticonvulsant activity; Blood-brain barrier; Cannabidiolic acid; Cannabis sativa extract; Epilepsy; Nanoliposomes; Nanostructured lipid carriers. 1
- biosimilars; clinical practice; interchangeability; extrapolation; pharmacovigilance; regulatory; knowledge; confidence; education 1
- Breast cancer, genomics, epigenomics, transcriptomics, proteomics, microbiomics 1
- breast cancer, proteomics 1
- cancer genetics, cancer epigenetic markers, cancer pharmacogenetics 1
- Cannabinoid potency, Cultivation, Flowers, Harvest, Hemp, Liquid chromatography, Trichome morphology. 1
- Cannabinoids; HPLC; Infrared spectroscopy; Marijuana; Plant material; TG/DTG; Δ9-tetrahydrocannabinol (THC) 1
- Cannabis sativa, sample preparation, analysis, quality control 1
- Cannabis sativa; sample preparation; analysis; quality control 1
- CD44 1
- colorectal cancer, biomolecular markers, tumor markers 1
- COVID-19, Remdesivir, Clinical practice, Clinical trials, Expanded access, Compassionate use, Early access scheme, Emergency use, Conditional approval 1
- cystic fibrosis, Health-Related Quality of Live, digest, daily activities 1
- Diclofenac sodium, PEO-PPO-PEO Ophthalmic micelles, FTIR, DSC, NMR, D-optimal design model, Mucus adhesion and permeation 1
- EGFR 1
- EGFR TKI resistance; co-delivery nanoparticles; combinatorial therapy; non-small cell lung cancer (NSCLC); overcoming and preventing resistance. 1